TapImmune CEO Discusses Company's Clinical Programs in Recent Print and Radio Interviews
| Monday, November 24, 2014 8:06 AM |

[PR Newswire] - SEATTLE, Nov. 24, 2014 /PRNewswire/ -- TapImmune, Inc. (OTCQB: TPIV), is pleased to point its shareholders to the following press articles published recently in which TapImmune CEO Dr Glynn Wilson has ...

http://us.rd.yahoo.com/finance/news/rss/story...00507.html

~ This Week's OTC News In Review! ~

Covering the entire market and teaching traders! Visit here to learn technicals and fundamentals >>
http://www.stockgoodies.com/lessons.html


~ http://www.fallenheroesfund.org/ ~
St. Jude 2014 Drive has started >> http://tinyurl.com/St-Jude-2014